A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer
Authors:
Open Access
- 4 March 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-17
Abstract
Tumor-associated neutrophils (TANs) can promote tumor progression. This study aimed to investigate the molecular signature that predict the prognosis and immune response of breast cancer (BRCA) based on TAN-related gene (TANRG) expression data. The RNA-seq data of BRCA were gathered from The Cancer Genome Atlas (TCGA) and gene expression omnibus (GEO) datasets. Univariate Cox regression analysis and the least absolute shrinkage and selection operator for selecting prognostic genes. A neo-TAN-related risk signature was constructed by multivariate Cox regression analysis. Time-dependent receiver operating characteristic (ROC) curve analyses and Kaplan–Meier analyses were performed to validate the signature in GEO cohorts and the triple-negative breast cancer (TNBC) subtype. We constructed an independent prognostic factor model with 11 TANRGs. The areas under the ROC curve (AUCs) of the TCGA training cohorts for 3-, 5-, and 7-year overall survival were 0.72, 0.73, and 0.73, respectively. The AUCs of the GEO test cohorts for 3-, 5-, and 7-year overall survival were 0.83, 0.89, and 0.94 (GSE25066) and 0.67, 0.69, and 0.73 (GSE58812), respectively. The proportion of immune subtypes differed among the different risk groups. The IC50 values differed significantly between risk groups and can be used as a guide for systemic therapy. The prognostic model developed by TANRGs has excellent predictive performance in BRCA patients. In addition, this feature is closely related to the prediction of survival, immune activity and treatment response in BRCA patients.Keywords
This publication has 33 references indexed in Scilit:
- CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancerCancer Immunology, Immunotherapy, 2022
- Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast CancerCurrent Oncology Reports, 2022
- Neutrophils as emerging immunotherapeutic targets: Indirect treatment of tumors by regulating the tumor immune environment based on a sialic acid derivative-modified nanocomplex platformInternational Journal of Pharmaceutics, 2022
- Current status of immune checkpoint inhibitors for gastric cancerGastric Cancer, 2020
- Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosisOral Oncology, 2020
- Identification of a 6‐lncRNA prognostic signature based on microarray re‐annotation in gastric cancerCancer Medicine, 2019
- The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancerBreast Cancer Research and Treatment, 2019
- Development and validation of an immune gene-set based Prognostic signature in ovarian cancerEBioMedicine, 2019
- IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell propertiesBiochemical and Biophysical Research Communications, 2017
- L1Penalized Estimation in the Cox Proportional Hazards ModelBiometrical Journal, 2010